Metoprolol Succinate ER in pharma franchise in Mizoram

Metoprolol Succinate ER in PCD pharma franchise in Bhopal

Metoprolol Succinate ER in top pharma company in Nagpur

Metoprolol Succinate ER in pcd pharma supplier in Pune

Metoprolol Succinate ER in phama franchise company in india
Metoprolol Succinate ER in phama distributor in Indore

Home/Products /metoprolol-succinate-release-25-mg-tablet

About the Product

Description


Metoperil XL 25 Tablet is an extended-release formulation containing Metoprolol Succinate 25 mg, a cardio-selective beta-1 blocker designed to manage various heart-related conditions with controlled, once-daily dosing. It helps in maintaining steady blood pressure levels, improving heart function, and preventing cardiovascular complications by reducing the workload on the heart and controlling heart rate.

This tablet is especially effective in the treatment of hypertension (high blood pressure), angina pectoris (chest pain), and in supporting the long-term management of chronic heart failure. By blocking the action of certain stress hormones like adrenaline on the heart, Metoperil XL 25 helps lower elevated blood pressure and reduces the frequency and severity of angina attacks.

The extended-release formulation ensures a gradual and sustained release of the active ingredient over 24 hours, allowing for consistent control of symptoms with improved patient compliance and reduced dosing frequency. This property also helps in avoiding sudden spikes or drops in drug concentration in the bloodstream, contributing to better blood pressure regulation.

Metoperil XL 25 is commonly prescribed as part of a comprehensive cardiovascular care plan. It may also be recommended for the prevention of migraines and as supportive therapy after a heart attack to prevent further cardiac events. Patients on this medication often experience improved exercise tolerance, reduced fatigue, and better control over stress-induced cardiac symptoms.

This formulation is generally well-tolerated when taken as prescribed. Patients are advised to maintain a healthy lifestyle, including a low-sodium diet, regular physical activity, and stress management, for maximum therapeutic benefit. It is important to take the tablet at the same time every day to maintain stable levels in the body.

May include fatigue, dizziness, slow heart rate, cold extremities, or sleep disturbances.

Indicated for the management of hypertension, angina, and chronic heart failure.

Do not stop the medication abruptly without consulting your physician, as it may worsen heart conditions.

Store in a cool, dry place below 30°C. Protect from moisture and sunlight.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Metoprolol Succinate 25 mg ER Tablets in the PCD pharma franchise market?

Metoprolol Succinate 25 mg ER (Extended Release) Tablets have strong demand in the cardiology and chronic care segment, making them a high-demand prescription product for pharma distributors, wholesalers, and franchise partners. It is widely prescribed for hypertension, angina, heart failure, arrhythmias, and cardiovascular risk management, ensuring consistent long-term prescription demand.

Why should medical distributors include Metoprolol Succinate 25 mg ER Tablets in their product range?

Medical distributors and agencies benefit from the growing prevalence of cardiovascular diseases and hypertension. Helps effectively manage high blood pressure Supports treatment of chronic stable angina Used in heart failure management under medical supervision Helps control certain cardiac rhythm disorders (arrhythmias) Extended-release formulation provides 24-hour therapeutic coverage with once-daily dosing Widely prescribed by cardiologists and general physicians Strong demand in hospital, clinic, and retail pharmacy segments This makes it a high-volume chronic cardiovascular care product with excellent repeat prescription potential.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Metoprolol Succinate 25 mg ER Tablets with monopoly rights, promotional support, quality manufacturing standards, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and franchise partners benefit from consistent cardiology prescription demand, long-term patient adherence, strong physician confidence, and stable year-round turnover in the cardiovascular segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and pharma franchise partners can contact Cafoli LifeCare Pvt Ltd to discuss monopoly territory rights, pricing structure, marketing support, and complete cardiology and antihypertensive product portfolio access to build a strong presence in the cardiovascular healthcare market.